Clinical Trials Directory

Trials / Completed

CompletedNCT02715635

Influence of Dietary Nitrate on Vascular Dysfunction and Inflammation

A Double-blind, Randomised, Placebo-controlled Parallel Study to Investigate the Effect of Dietary Nitrate on a Model of Vascular Dysfunction in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Queen Mary University of London · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The principal research objective is to determine whether inorganic nitrate in the form of beetroot juice compared to placebo control prevents the systemic inflammation that underlies typhoid vaccine-induced endothelial dysfunction

Detailed description

We wish to determine in a prospective manner whether inorganic nitrate affects the endothelial dysfunction induced by systemic inflammation. At baseline we will measure flow-mediated dilatation (FMD) and peripheral augmentation index, as well as aortic stiffness, as measured by pulse wave velocity (PWV). Volunteers will then receive \~8 mmols of dietary nitrate or nitrate free placebo juice once daily for 6 days. After this, depending on availability, volunteers will receive a typhoid vaccine Typherix®, GlaxoSmithKline UK or Typhim Vi ™, AAH Pharmaceuticals Ltd). This vaccine generates a mild systemic inflammation that is associated with vascular dysfunction. All vascular function measures will be repeated at 8 hours and 32 hours after vaccine administration.

Conditions

Interventions

TypeNameDescription
BIOLOGICALTyphoid vaccineThe typhoid vaccine is composed of purified polysaccharide from S. typhi capsule 25 micrograms contained in 0.5 ml solution
DIETARY_SUPPLEMENTConcentrate beetroot Juice140 ml containing \~8 mmol of inorganic nitrate
DIETARY_SUPPLEMENTConcentrate beetroot Juice (Placebo)140 ml which is nitrate-depleted

Timeline

Start date
2016-04-01
Primary completion
2020-12-01
Completion
2021-08-01
First posted
2016-03-22
Last updated
2022-07-20

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02715635. Inclusion in this directory is not an endorsement.